Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 11, Issue 20
|
pp. 9043–9059
T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma
Back to article
Figure 4
(4 of 7)
−
100%
+
Figure 4.
Cellular viability of glioblastoma cells treated with RSPO2 and AZD5363.
